CLINICAL_TRIALS
trial_result
· 2011-07-29
Clinical Trial Update: Study Evaluating the Safety and Effects of MN-221 in Subjects Experiencing an Acute Exacerbation of Asthma [Phase 2]
Summary
A Phase 2 trial evaluating MN-221 in subjects with acute exacerbation of asthma was terminated, with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: MediciNova | Conditions: Asthma, Status Asthmaticus | Phase 2 | Status: TERMINATED | Results posted: 2011-07-29